MA-5, which is isolated from the plant hormone indole-3-acetic acid [21], has been tested for treatment in patients with mitochondrial disease, cardiac myocyte damage and renal tubular injury [32]. Here, PNMA3 is linked to inborn mitochondrial metabolism disorder.